Islet transplantation in the discordant tilapia-to-mouse model: a novel application of alginate microencapsulation in the study of xenograft rejection

小岛 移植 单克隆抗体 抗体 腹膜腔 免疫学 医学 CD8型 T细胞 链脲佐菌素 癌症研究 免疫系统 生物 糖尿病 内分泌学 内科学 解剖
作者
Brendan C. Dickson,Hua Yang,H.F.J. Savelkoul,Geoff Rowden,Nico van Rooijen,James R. Wright
出处
期刊:Transplantation [Wolters Kluwer]
卷期号:75 (5): 599-606 被引量:20
标识
DOI:10.1097/01.tp.0000048226.28357.0d
摘要

Tilapia islet xenograft rejection is characterized by infiltration with macrophages (Mphis), eosinophils (Ephis), and T lymphocytes. The presence of these cells indicates they contribute to rejection; therefore, an attempt was made to assess their role through host immunomodulation.Tilapia islet cells were transplanted under the kidney capsule of streptozotocin diabetic Balb/c mice, which were then treated with one of several immunomodulatory regimes targeting Mphis, Ephis, or T cells. Mphis were depleted using either silica or liposome-entrapped Cl2MDP. Ephi migration was blocked using monoclonal antibodies (mAbs) targeting interleukin (IL)-4 or IL-5. T-cell function was altered with mAbs targeting CD3, CD4, or CD8. Finally, T helper (Th)1 and Th2 activity was altered by depleting essential Th1 or Th2 cytokines with mAbs or by promoting a Th1 response with the injection of exogenous IL-12. The effects of antibody-mediated immunomodulation on graft survival were initially screened by cotransplanting alginate-encapsulated, mAb-secreting hybridoma cells into the peritoneal cavity at the time of islet transplantation. Significant prolongation was then confirmed using purified antibodies injected at the time of islet transplantation. Rejected grafts were examined histologically, and immunohistochemistry was used to assess the cellular infiltrates for each of the treatment groups.Modulation of Mphis and Ephis alone did not significantly delay functional rejection of tilapia islet grafts (maximal mean graft survival time [mGST]=7.1+/-1.7 and 9.4+/-3.4, respectively) compared with untreated controls (mGST=8.2+/-1.0). Treatment of transplanted animals with antibodies against CD3 or CD4 significantly promoted graft survival (maximal mGST=16.3+/-5.8 and 34.0+/-11.6, respectively), whereas targeting CD8 and Th1 and Th2 cytokines showed no prolonging effect (maximal mGST=7.8+/-2.9 and 9.5+/-4.3, respectively).Our results indicate that rejection in the tilapia-to-mouse model follows a pattern similar to other models of discordant islet cell xenotransplantation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研小菜鸡完成签到 ,获得积分10
1秒前
牛人完成签到,获得积分0
2秒前
科研通AI6.1应助LLddww采纳,获得10
3秒前
现代宝宝完成签到,获得积分10
3秒前
缓慢的冬云完成签到,获得积分0
3秒前
小石头完成签到,获得积分10
4秒前
无与伦比完成签到,获得积分10
4秒前
马超放烟花完成签到,获得积分10
6秒前
量子星尘发布了新的文献求助10
8秒前
hhh123完成签到,获得积分10
10秒前
dong完成签到 ,获得积分10
11秒前
李健的小迷弟应助多边棱采纳,获得10
12秒前
yxl01yxl完成签到,获得积分10
12秒前
nano完成签到 ,获得积分10
12秒前
77鱼完成签到,获得积分10
13秒前
哔哩哔哩往上爬完成签到,获得积分10
13秒前
jiang完成签到 ,获得积分10
14秒前
所所应助niko采纳,获得10
14秒前
Hello应助niko采纳,获得10
14秒前
Owen应助niko采纳,获得10
14秒前
Jasper应助niko采纳,获得10
15秒前
星辰大海应助niko采纳,获得10
15秒前
SciGPT应助niko采纳,获得10
15秒前
酷波er应助niko采纳,获得10
15秒前
今后应助niko采纳,获得10
15秒前
川Q邓紫棋完成签到 ,获得积分10
15秒前
JamesPei应助niko采纳,获得10
15秒前
Lucas应助niko采纳,获得10
15秒前
16秒前
强小强努力努力完成签到,获得积分10
17秒前
wang完成签到 ,获得积分10
17秒前
gdgd完成签到,获得积分10
17秒前
sen123完成签到,获得积分10
19秒前
1168163完成签到,获得积分10
19秒前
卡哇意完成签到 ,获得积分10
23秒前
机智的阿振完成签到,获得积分10
23秒前
FOD完成签到 ,获得积分10
24秒前
mmr完成签到,获得积分10
24秒前
蓝莓橘子酱完成签到,获得积分0
26秒前
花花花完成签到,获得积分20
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aerospace Standards Index - 2026 ASIN2026 3000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Research Methods for Business: A Skill Building Approach, 9th Edition 500
Social Work and Social Welfare: An Invitation(7th Edition) 410
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6051428
求助须知:如何正确求助?哪些是违规求助? 7860428
关于积分的说明 16267983
捐赠科研通 5196426
什么是DOI,文献DOI怎么找? 2780663
邀请新用户注册赠送积分活动 1763592
关于科研通互助平台的介绍 1645632